Sezary Syndrome - 21 Studies Found
Completed |
: Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome : Lymphoma : 1999-11-01 : Drug: tretinoin |
Terminated |
: Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome : Lymphoma : 2000-06-02 : Biological: aldesleukin |
Active, not recruiting |
: Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome : Lymphoma : 2003-04-07 : Biological: alemtuzumab Will be administered as a two-hour IV infusion with a target dose of 30 milligra |
Recruiting |
: ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome :
: 2016-07-25 |
Completed |
: Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma :
|
Recruiting |
: Tissue Repository: CTCL Collection Protocol :
|
Active, not recruiting |
: Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome : Lymphoma : 2007-04-25 : Drug: lenalidomide 10 mg daily orally administered on days 1 - 21 followed by 7 days rest of a 28-day cy |
Completed |
: Effect of Denileukin Diftitox on Immune System in CTCL Patients :
|